|
Market Closed -
Bombay S.E.
06:02:23 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 173.60 INR | -4.51% |
|
-2.55% | +2.06% |
| Market Cap | 552M 5.78M 5.01M 4.7M 4.28M 8.05M 8.18M 55.23M 21.59M 276M 21.72M 21.25M 921M | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 519M 5.45M 4.72M 4.42M 4.03M 7.58M 7.7M 51.99M 20.32M 260M 20.44M 20M 867M | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 day | -4.51% | ||
| 1 week | -2.55% | ||
| Current month | -1.87% | ||
| 1 month | -0.74% | ||
| 3 months | +34.52% | ||
| 6 months | +23.25% | ||
| Current year | +2.06% |
| 1 week | 171.5 |  | 184 |
| 1 month | 167 | | 184 |
| Current year | 100.1 | | 184 |
| 1 year | 100.1 | | 220 |
| 3 years | 100.1 | | 398 |
| 5 years | 97.4 | | 398 |
| 10 years | 21.5 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 2016-08-20 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 2005-10-06 |
| Compliance Officer | - | 2020-08-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2005-12-11 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 2005-10-06 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 2016-08-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.51% | -2.55% | -8.08% | +10.57% | 6.06M | |
| +0.43% | +4.31% | +90.84% | +126.82% | 1,083B | |
| +0.41% | +1.27% | +50.98% | +50.40% | 626B | |
| -0.53% | +1.04% | +25.23% | +63.37% | 442B | |
| -0.92% | +2.18% | +48.40% | +37.85% | 363B | |
| -1.32% | -0.32% | +29.35% | +36.81% | 295B | |
| -1.20% | -0.32% | +6.03% | +6.09% | 248B | |
| +0.45% | +2.05% | +46.04% | +59.47% | 224B | |
| -2.51% | -2.63% | -7.16% | -51.74% | 210B | |
| +0.07% | +3.12% | +13.21% | +70.16% | 168B | |
| Average | -1.08% | +2.80% | +29.48% | +40.98% | 365.91B | |
| Weighted average by Cap. | -0.26% | +4.29% | +49.25% | +64.85% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 340M 3.56M 3.09M 2.89M 2.64M 4.96M 5.04M 34.02M 13.3M 170M 13.38M 13.09M 568M | 357M 3.75M 3.25M 3.04M 2.77M 5.21M 5.29M 35.76M 13.98M 179M 14.06M 13.76M 596M |
| Net income | 42.46M 445K 386K 361K 330K 620K 629K 4.25M 1.66M 21.26M 1.67M 1.64M 70.9M | 57.89M 607K 526K 493K 449K 845K 858K 5.79M 2.27M 28.99M 2.28M 2.23M 96.66M |
| Net Debt | -36.87M -387K -335K -314K -286K -538K -546K -3.69M -1.44M -18.46M -1.45M -1.42M -61.56M | -32.39M -340K -294K -276K -251K -473K -480K -3.24M -1.27M -16.22M -1.28M -1.25M -54.09M |
Employees
42
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | ₹173.60 | -4.51% | 3,295 |
| 26-08-11 | ₹181.80 | +0.44% | 996 |
| 26-08-10 | ₹181.00 | +1.63% | 366 |
| 26-08-07 | ₹178.10 | +2.18% | 1,083 |
| 26-08-06 | ₹174.30 | +0.55% | 671 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
